Efficacy and safety of yttrium-90 ibritumomab tiuxetan in Japanese patients with non-Hodgkin lymphoma

ISSN： 1867-1071

Source： Japanese Journal of Radiology, Vol.30, Iss.8, 2012-10, pp. : 642-647

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with ⁹⁰Y-radiolabelled ibritumomab tiuxetan (Zevalin)

By Tennvall Jan Fischer Manfred Bischof Delaloye Angelika Bombardieri Emilio Bodei Lisa Giammarile Francesco Lassmann Michael Oyen Wim Brans Boudewijn

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 616-622

Springer Publishing Company

Access to resources Recommend Favorite

Non-Hodgkin Lymphoma: Pattern of Disease at Spiral CT

By Sheth Sheila Fishman Elliot K.

Critical Reviews in Computed Tomography, Vol. 42, Iss. 6, 2001-11 ,pp. : 307-356

Informa Healthcare

Access to resources Recommend Favorite

Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin's Lymphoma: Statistical Errors in Fueger et al . (2009)

By White Larry

Molecular Imaging and Biology, Vol. 14, Iss. 4, 2012-08 ,pp. : 397-398

Springer Publishing Company

Access to resources Recommend Favorite

Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow

By Daldrup-Link Heike Rummeny Ernst Ihssen Bettina Kienast Joachim Link Thomas

European Radiology, Vol. 12, Iss. 6, 2002-06 ,pp. : 1557-1566

Springer Publishing Company

Access to resources Recommend Favorite

Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma

By Hassler Melanie R Schiefer Ana-Iris Egger Gerda

Epigenomics, Vol. 5, Iss. 4, 2013-08 ,pp. : 397-415

Future Medicine

Access to resources Recommend Favorite